The store will not work correctly when cookies are disabled.
3-(5-(3-(Methylsulfonyl)phenyl)imidazo[2,1-b]thiazol-6-yl)phenol
ID: ALA4860208
PubChem CID: 162421456
Max Phase: Preclinical
Molecular Formula: C18H14N2O3S2
Molecular Weight: 370.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)c1cccc(-c2c(-c3cccc(O)c3)nc3sccn23)c1
Standard InChI: InChI=1S/C18H14N2O3S2/c1-25(22,23)15-7-3-5-13(11-15)17-16(12-4-2-6-14(21)10-12)19-18-20(17)8-9-24-18/h2-11,21H,1H3
Standard InChI Key: BPCPNNHGXWZUIA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
18.4191 -10.6907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7066 -11.1073 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.4237 -11.5159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6815 -6.9747 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.8969 -7.2317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8969 -8.0566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6815 -8.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1661 -7.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1123 -6.9747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6276 -7.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1123 -8.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1554 -10.4951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4124 -9.7105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8594 -9.0983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0493 -9.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7963 -10.0511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3494 -10.6675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8027 -7.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3902 -8.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5653 -8.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1528 -7.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5653 -6.9326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3902 -6.9326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1528 -9.0716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4516 -11.8929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
4 8 1 0
9 10 1 0
10 11 2 0
5 9 2 0
6 11 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
11 14 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
20 24 1 0
10 18 1 0
12 2 1 0
2 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 370.46 | Molecular Weight (Monoisotopic): 370.0446 | AlogP: 3.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.67 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.56 | CX Basic pKa: 3.26 | CX LogP: 2.93 | CX LogD: 2.93 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -1.60 |
References
1. Zaraei SO, Sbenati RM, Alach NN, Anbar HS, El-Gamal R, Tarazi H, Shehata MK, Abdel-Maksoud MS, Oh CH, El-Gamal MI.. (2021) Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors., 224 [PMID:34237622] [10.1016/j.ejmech.2021.113674] |